164 related articles for article (PubMed ID: 15695135)
1. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator.
Chiu JH; Abdelhadi RH; Chung MK; Gurm HS; Marrouche NF; Saliba WI; Natale A; Martin DO
Am J Cardiol; 2005 Feb; 95(4):490-1. PubMed ID: 15695135
[TBL] [Abstract][Full Text] [Related]
2. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
[TBL] [Abstract][Full Text] [Related]
3. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
[TBL] [Abstract][Full Text] [Related]
4. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
Wanahita N; Chen J; Bangalore S; Shah K; Rachko M; Coleman CI; Schweitzer P
Am J Ther; 2012 Jan; 19(1):16-23. PubMed ID: 20720485
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the intensity rate of appropriate shocks for ventricular arrhythmias with statin therapy.
Beri A; Contractor T; Gardiner JC; Ardhanari S; Thakur R
J Cardiovasc Pharmacol; 2010 Aug; 56(2):190-4. PubMed ID: 20505523
[TBL] [Abstract][Full Text] [Related]
6. Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease.
Riahi S; Schmidt EB; Christensen JH; Heath F; Pedersen AK; Nielsen JC; Mølgaard H; Toft E
Cardiology; 2005; 104(4):210-4. PubMed ID: 16155396
[TBL] [Abstract][Full Text] [Related]
7. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Dickinson MG; Ip JH; Olshansky B; Hellkamp AS; Anderson J; Poole JE; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2007 Apr; 153(4):573-8. PubMed ID: 17383296
[TBL] [Abstract][Full Text] [Related]
8. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
Whang W; Albert CM; Sears SF; Lampert R; Conti JB; Wang PJ; Singh JP; Ruskin JN; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2005 Apr; 45(7):1090-5. PubMed ID: 15808769
[TBL] [Abstract][Full Text] [Related]
9. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy.
Sumner AD; Boehmer JP; Saxon LA; Carson P; Feldman AM; Galle E; Bristow MR
Congest Heart Fail; 2009; 15(4):159-64. PubMed ID: 19627288
[TBL] [Abstract][Full Text] [Related]
10. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
[TBL] [Abstract][Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
12. Statin therapy significantly reduces risk of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
Jacob S; Manickam P; Rathod A; Badheka A; Afonso L; Aravindhakshan R
Am J Ther; 2012 Jul; 19(4):261-8. PubMed ID: 21048429
[TBL] [Abstract][Full Text] [Related]
13. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillators.
Aronow WS
Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
[TBL] [Abstract][Full Text] [Related]
15. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease.
Bunch TJ; Kottke TE; Lopez-Jimenez F; Mahapatra S; Elesber AA; White RD
Am J Cardiol; 2006 Oct; 98(7):857-60. PubMed ID: 16996862
[TBL] [Abstract][Full Text] [Related]
17. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator.
Kolb C; Zrenner B; Schmitt C
Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
Lai HM; Aronow WS; Kruger A; Desai H; Amin H; Frishman WH; Cohen M; Sorbera C
Am J Cardiol; 2008 Jul; 102(1):77-8. PubMed ID: 18572039
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
